Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Sell
9,687
-55
-0.6% -$13.9K 1.23% 17
2026
Q1
$2.36M Buy
+9,742
New +$2.64M 1.19% 17
2025
Q3
$2.73M Buy
9,672
+119
+1% +$31.1K 1.43% 13
2025
Q2
$2.82M Sell
9,553
-142
-1% -$36.6K 1.61% 11
2025
Q1
$2.41M Buy
9,695
+11
+0.1% +$2.69K 1.46% 11
2024
Q4
$2.13M Buy
9,684
+83
+0.9% +$18.5K 1.29% 13
2024
Q3
$2.12M Sell
9,601
-174
-2% -$34.1K 1.3% 13
2024
Q2
$1.69M Sell
9,775
-75
-0.8% -$13K 1.09% 16
2024
Q1
$1.88M Buy
9,850
+16
+0.2% +$2.92K 1.25% 12
2023
Q4
$1.61M Buy
9,834
+40
+0.4% +$6.04K 1.16% 15
2023
Q3
$1.37M Buy
9,794
+8
+0.1% +$1.14K 1.13% 18
2023
Q2
$1.31M Buy
9,786
+65
+0.7% +$8.39K 1.05% 20
2023
Q1
$1.27M Buy
9,721
+459
+5% +$61.4K 1.15% 15
2022
Q4
$1.3M Buy
9,262
+54
+0.6% +$7.45K 1.36% 14
2022
Q3
$1.09M Buy
9,208
+559
+6% +$73.4K 1.28% 16
2022
Q2
$1.22M Sell
8,649
-64
-0.7% -$8.64K 1.37% 15
2022
Q1
$1.13M Buy
8,713
+648
+8% +$84.5K 1.07% 17
2021
Q4
$1.08M Buy
+8,065
New +$1.01M 0.99% 19

Other funds holding IBM

Mendel Capital Management's IBM Position: Q2 2026 in Review

Mendel Capital Management reduced its IBM (IBM) stake by 0.56% in Q2 2026, selling an estimated $13.9K and leaving 9,687 shares worth $2.72M. The position accounts for 1.23% of the portfolio, ranked #17.

Mendel Capital Management first reported a position in IBM in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.82M in Q2 2025. 1,810 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Mendel Capital Management held 9,687 shares of IBM worth $2.72M as of Q2 2026.
  • Mendel Capital Management sold 55 IBM shares in Q2 2026, an estimated $13.9K.
  • IBM made up 1.23% of Mendel Capital Management's portfolio in Q2 2026, its #17 holding.
  • Mendel Capital Management first reported a position in IBM in Q4 2021 and has held it in 18 quarters since.
  • Mendel Capital Management's IBM position peaked at $2.82M in Q2 2025.
  • 1,810 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Mendel Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.